CNS Pharmaceuticals Inc (CNSP)
2.79
-0.83
(-22.93%)
USD |
NASDAQ |
Jun 14, 16:00
2.80
+0.01
(+0.36%)
After-Hours: 20:00
CNS Pharmaceuticals Enterprise Value: 0.3046M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 0.3046M |
| June 13, 2024 | 0.5744M |
| June 12, 2024 | 0.4151M |
| June 11, 2024 | 0.5191M |
| June 10, 2024 | 0.5841M |
| June 07, 2024 | 1.039M |
| June 06, 2024 | 1.137M |
| June 05, 2024 | 1.150M |
| June 04, 2024 | 1.492M |
| June 03, 2024 | 0.9384M |
| May 31, 2024 | 1.960M |
| May 30, 2024 | 1.976M |
| May 29, 2024 | 1.902M |
| May 28, 2024 | 1.826M |
| May 24, 2024 | 1.880M |
| May 23, 2024 | 1.948M |
| May 22, 2024 | 1.850M |
| May 21, 2024 | 1.946M |
| May 20, 2024 | 1.958M |
| May 17, 2024 | 1.969M |
| May 16, 2024 | 2.063M |
| May 15, 2024 | 1.763M |
| May 14, 2024 | 1.614M |
| May 13, 2024 | 1.575M |
| May 10, 2024 | 1.485M |
| Date | Value |
|---|---|
| May 09, 2024 | 1.628M |
| May 08, 2024 | 1.959M |
| May 07, 2024 | 1.713M |
| May 06, 2024 | 1.546M |
| May 03, 2024 | 1.749M |
| May 02, 2024 | 1.690M |
| May 01, 2024 | 1.716M |
| April 30, 2024 | 1.646M |
| April 29, 2024 | 1.684M |
| April 26, 2024 | 1.684M |
| April 25, 2024 | 1.567M |
| April 24, 2024 | 1.674M |
| April 23, 2024 | 1.631M |
| April 22, 2024 | 1.515M |
| April 19, 2024 | 1.546M |
| April 18, 2024 | 1.567M |
| April 17, 2024 | 1.572M |
| April 16, 2024 | 1.615M |
| April 15, 2024 | 1.994M |
| April 12, 2024 | 1.986M |
| April 11, 2024 | 1.950M |
| April 10, 2024 | 1.863M |
| April 09, 2024 | 1.833M |
| April 08, 2024 | 1.780M |
| April 05, 2024 | 2.148M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-8.047M
Minimum
Mar 28 2023
86.09M
Maximum
Feb 08 2021
20.02M
Average
10.16M
Median
Nov 16 2023
Enterprise Value Benchmarks
| SIGA Technologies Inc | 330.52M |
| Moderna Inc | 45.14B |
| Calidi Biotherapeutics Inc | 16.86M |
| NovaBay Pharmaceuticals Inc | 3.382M |
| Palatin Technologies Inc | 19.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.545M |
| Total Expenses (Quarterly) | 3.545M |
| EPS Diluted (Quarterly) | -20.50 |
| Earnings Yield | -6.08K% |